Antibe Therapeutics (OTCMKTS:ATBPF – Get Free Report) announced its quarterly earnings data on Wednesday. The company reported ($0.06) EPS for the quarter, topping the consensus estimate of ($0.09) by $0.03, reports. Antibe Therapeutics Stock Up 1.7 % OTCMKTS:ATBPF traded up $0.01 during mid-day trading on Friday, hitting $0.70. 3,799 shares of the stock traded hands, […]
Antibe Reports Q3 2024 Interim Financial and Operating Results streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Antibe Therapeutics Inc. (TSE:ATE – Get Free Report) crossed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of C$0.92 and traded as high as C$0.97. Antibe Therapeutics shares last traded at C$0.95, with a volume of 60,000 shares changing hands. Antibe Therapeutics Stock Performance […]
Antibe Therapeutics Inc. (OTCMKTS:ATBPD – Get Free Report) shares hit a new 52-week low on Thursday . The stock traded as low as $0.71 and last traded at $0.71, with a volume of 1000 shares. The stock had previously closed at $0.71. Antibe Therapeutics Stock Performance The firm has a fifty day moving average of […]
TORONTO (BUSINESS WIRE) $ATBPF Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies that target inflammation, is extending the Early Warrant Exercise Incentive Program (“Early Warrant Exercise Program”) for.